SANMINA APPOINTS JON FAUST AS EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
Get Alerts SANM Hot Sheet
Join SI Premium – FREE
Faust brings over 20 years of finance, accounting, controls, and operations experience in large, public, multinational companies. Faust previously served as Global Controller and Head of Finance Transformation & Corporate Services at HP Inc., which he joined in
"We are excited to have Jon join Sanmina. He is a highly accomplished leader with a proven track record of driving transformational business strategies and demonstrated expertise in leading large, multinational organizations. I am confident that his experience and strong financial acumen make him a great addition to our leadership team as we continue to execute our long-term growth strategy and maximize shareholder value," stated
"We thank Kurt for his contributions to the organization during his tenure and wish him well in his future endeavors."
About Sanmina
Sanmina Corporation, a Fortune 500 company, is a leading integrated manufacturing solutions provider serving the fastest growing segments of the global Electronics Manufacturing Services (EMS) market. Recognized as a technology leader, Sanmina provides end-to-end manufacturing solutions, delivering superior quality and support to Original Equipment Manufacturers (OEMs) primarily in the industrial, medical, defense and aerospace, automotive, communications networks and cloud infrastructure markets. Sanmina has facilities strategically located in key regions throughout the world. More information about the Company is available at www.sanmina.com.
Sanmina Contact
SVP, Investor Communications
408-964-3610
Logo - https://mma.prnewswire.com/media/10544/SANMINA_CORPORATION_LOGO.jpg
View original content:https://www.prnewswire.com/news-releases/sanmina-appoints-jon-faust-as-executive-vice-president-and-chief-financial-officer-302005604.html
SOURCE Sanmina Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
- Shiba Inu Price Prediction: SHIB Bulls Target a Recovery as Remittix Approaches Its Final Presale Phase
- Cardano Price Prediction: ADA Holds Onto Weekly Gains as Remittix Targets Its Next Major Breakout
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share